24 HR dexmethylphenidate hydrochloride 15 MG Extended Release Oral Capsule
1 INDICATIONS AND USAGE Dexmethylphenidate HCl extended-release capsules are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) [ see Clinical Studies ( 14 ) ]. Dexmethylphenidate HCl extended-release capsules are a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) ( 1 ).
lannett company, inc.
Related Pills
dexmethylphenidate 30 mg
lannett company, inc.
montelukast sodium tablet chewable montelukast sodium tablet
torrent pharmaceuticals limited
amlodipine besylate tablet
par pharmaceutical
amlodipine besylate tablet
par pharmaceutical
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING Dexmethylphenidate HCl extended-release capsules are available as follows: 5 mg extended-release capsules (NDC 0527-8106-37) are blue (imprinted 106), capsule-shaped and supplied in bottles of 100 10 mg extended-release capsules (NDC 0527-8107-37) are clear containing white to off-white beads (imprinted 107) supplied in bottles of 100 15 mg extended-release capsules (NDC 0527-8108-37) are light green (imprinted 108), capsule-shaped and supplied in bottles of 100 20 mg extended-release capsules (NDC 0527-8109-37) are white (imprinted 109), capsule-shaped and supplied in bottles of 100 25 mg extended-release capsules (NDC 0527-8110-37) are blue and white (imprinted 110), capsule-shaped and supplied in bottles of 100 30 mg extended-release capsules (NDC 0527-8111-37) are clear and white containing white to off-white beads (imprinted 111), capsule-shaped and supplied in bottles of 100 35 mg extended-release capsules (NDC 0527-8112-37) are blue and clear containing white to off-white beads (imprinted 112), capsule-shaped and supplied in bottles of 100 40 mg extended-release capsules (NDC 0527-8113-37) are light green and white (imprinted 113), capsule-shaped and supplied in bottles of 100 Store at 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F to 86°F) [See USP Controlled Room Temperature]. Dispense in tight container (USP). Disposal Comply with local laws and regulations on drug disposal of CNS stimulants. Dispose of remaining, unused, or expired dexmethylphenidate HCl extended-release capsules by a medicine take-back program or by an authorized collector registered with the Drug Enforcement Administration. If no take-back program or authorized collector is available, mix dexmethylphenidate HCl extended-release capsules with an undesirable, non-toxic substance to make it less appealing to children and pets. Place the mixture in a container such as a sealed plastic bag and discard dexmethylphenidate HCl extended-release capsules in the household trash.
More pills like CAPSULE 108